Effective Date: April 18, 2026
Last Updated: April 18, 2026
By accessing or using GLP-1 Cost Finder (the "Website"), you agree to be bound by these Terms of Use. If you do not agree, please do not use the Website. We may update these Terms at any time; continued use after changes constitutes acceptance of the updated Terms.
GLP-1 Cost Finder is an educational price comparison tool for GLP-1 medications (such as Ozempic, Wegovy, Mounjaro, Zepbound, and Foundayo). We aggregate publicly available pricing, coverage, and program information from manufacturers, pharmacies, telehealth providers, and government sources to help you understand your options.
This Website does not provide medical advice, diagnosis, or treatment. It is not a substitute for professional medical care.
We are not physicians, pharmacists, nurses, or licensed healthcare professionals. Nothing on this Website constitutes medical advice. You should always consult a qualified healthcare provider before:
Your reliance on any information provided here is solely at your own risk. Individual responses to medication, eligibility, and pricing vary.
Some links on this Website are affiliate links. If you click through and take a qualifying action (such as starting a telehealth consultation or filling a prescription), we may earn a commission at no additional cost to you.
Affiliate relationships do not influence our comparisons or recommendations. We rank options by the same criteria regardless of whether a partner pays a commission. When affiliate links exist alongside non-affiliate alternatives, we include both so you can make an informed choice.
Drug pricing, manufacturer savings programs, insurance formularies, and pharmacy availability change frequently and without notice. Prices shown on this Website are estimates compiled from publicly available sources at a specific point in time and may not reflect the price you are actually charged.
Before purchasing or enrolling, verify the current price, eligibility requirements, and terms directly with the pharmacy, manufacturer, telehealth provider, or insurer. We are not responsible for discrepancies between information on this Website and information provided by third parties at the time of your transaction.
All original content on this Website—including text, layout, recommendation logic, coverage tables, and compiled data sets—is the property of Olson Coaches and is protected by U.S. copyright law. You may view and share individual pages for personal, non-commercial use. You may not scrape, copy, republish, or redistribute our content, in whole or in part, for commercial purposes without prior written permission.
Trademarks, brand names, and product names referenced on this Website (such as Ozempic®, Wegovy®, Mounjaro®, Zepbound®) are the property of their respective owners and are used for identification only. Mention of a brand does not imply endorsement by that brand of this Website.
To the fullest extent permitted by law, Olson Coaches, Dean Olson, and any contributors to this Website are not liable for any direct, indirect, incidental, consequential, special, or punitive damages arising from:
This Website is provided "as is" and "as available" without warranties of any kind, express or implied.
These Terms are governed by the laws of the State of Washington, without regard to its conflict-of-laws principles. Any dispute arising out of or relating to these Terms or your use of the Website shall be resolved exclusively in the state or federal courts located in Washington, and you consent to personal jurisdiction in those courts.
Questions about these Terms? Contact:
Dean Olson
Olson Coaches
Email: dean@olsoncoaches.com
© 2026 Olson Coaches|About|Privacy Policy|Terms of Use|Contact|Pricing Guides
Guides:Cheapest GLP-1 Without Insurance·Ozempic vs Mounjaro Cost·Self-Pay Options
Tools:Medicare Bridge eligibility checker·Provider legitimacy checker
Medicare:Bridge Program 2026 guide
Affiliate Disclosure: We may earn commissions from partner links.
Sources: TrumpRx.gov, GoodRx, NovoCare, LillyDirect, CMS, KFF, FDA.gov